Skip to main content

ESMO Highlights

Meeting Highlights
ESMO Highlights
Efficacy and Safety of Front-Line Veliparib and Paclitaxel Weekly versus Every 3 Weeks in the VELIA Study
Read More
Meeting Highlights
ESMO Highlights
Targeted Therapy with Olaparib Beneficial in Metastatic Prostate Cancer with Gene Mutations
Phoebe Starr
Read More
Meeting Highlights
ESMO Highlights
Ceritinib Effective in Treating Brain Metastases in NSCLC
Phoebe Starr
Read More
Meeting Highlights
ESMO Highlights
Paradigm Shift: PARP Inhibitors Should Be Offered to All Patients with Ovarian Cancer
Phoebe Starr
Read More
Meeting Highlights
Breast Cancer, ESMO Highlights
Adding CDK4/6 Inhibitor to Endocrine Therapy Improves Survival in Advanced Breast Cancer: New Standard of Care
Phoebe Starr
Read More
Meeting Highlights
ESMO Highlights
Adjuvant Innovative Peptide Vaccine Therapy Shows Promising Activity in Early-Stage Triple Negative Breast Cancer
Read More
Meeting Highlights
ESMO Highlights
Breaking News from the 2018 Meeting of the European Society for Medical Oncology (ESMO)
Read More
Meeting Highlights
ESMO Highlights
A Meta-Analysis to Evaluate the Risk for Fatigue in Patients Treated with Olaparib for Advanced Cancer
Read More
Meeting Highlights
ESMO Highlights
A Phase 1b and Randomized Phase 2 Trial of Pazopanib with or Without Fosbretabulin in Advanced Recurrent Ovarian Cancer
Read More
Meeting Highlights
ESMO Highlights
The Efficacy of Apatinib Treatment for Advanced Ovarian Cancer After Second-Line Chemotherapy Failure
Read More
Page 3 of 5
Results 21 - 30 of 44